ACR board will not pursue near-term sale

Asia Capital Re (ACR)'s board will not reopen the sales
process that led to its $1bn abortive deal with Shenzhen Qianhai
Financial Holdings and Shenzhen Investment Holdings,
The Insurance Insider understands.
Sources said that there was a danger that any attempt to re-run
the auction held in 2016 would be perceived as a fire sale and
result in a weak valuation of the reinsurer.
It is understood instead that the board is minded to hold onto
the asset and give...